0001484612-22-000017.txt : 20220203 0001484612-22-000017.hdr.sgml : 20220203 20220203161148 ACCESSION NUMBER: 0001484612-22-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vazquez Martin CENTRAL INDEX KEY: 0001823380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39513 FILM NUMBER: 22588388 MAIL ADDRESS: STREET 1: 3052 ORCHARD DR. CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outset Medical, Inc. CENTRAL INDEX KEY: 0001484612 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 200514392 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 669-231-8200 MAIL ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: Home Dialysis Plus, Ltd. DATE OF NAME CHANGE: 20100219 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-02-01 0 0001484612 Outset Medical, Inc. OM 0001823380 Vazquez Martin 3052 ORCHARD DRIVE SAN JOSE CA 95134 0 1 0 0 Chief Operating Officer Common Stock 2022-02-01 4 M 0 5000 8.62 A 55525 D Common Stock 2022-02-01 4 S 0 5000 37.4396 D 50525 D Non-Qualified Stock Option (right to buy) 8.62 2022-02-01 4 M 0 5000 0.0 D 2030-02-03 Common Stock 5000 67151 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $36.00-$36.99 - 700 shares; $37.00-$37.99 - 4,146 shares; $38.00-$38.99 - 154 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option vests in 48 equal monthly installments beginning on March 3, 2020, subject to the reporting person's continued employment through the applicable vesting date. By: John L Brottem For: Martin Vazquez 2022-02-03